Acinetobacter baumannii 1a1s_1969 recombinant protein and its preparation method and application

An Acinetobacter baumannii, recombinant protein technology, applied in the biological field, can solve the problems of complex composition of outer membrane complex, complex vaccine composition, large toxic and side effects, etc., to maintain spatial conformation and immunogenicity, and to achieve controllable quality and safety , the effect of simple steps

Active Publication Date: 2018-06-08
ARMY MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, Acinetobacter baumannii has not entered clinical research at home and abroad. The selection of dominant antigens is very important in the research and development of vaccines. Traditional whole-bacteria vaccines contain complex vaccine components and have certain toxic and side effects, so the safety is not high.
At present, some foreign scholars have conducted preliminary research on the outer membrane complex vaccine of Acinetobacter baumannii, but the outer membrane complex has complex components and contains a large amount of endotoxin, which has great toxic and side effects on the body.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Acinetobacter baumannii 1a1s_1969 recombinant protein and its preparation method and application
  • Acinetobacter baumannii 1a1s_1969 recombinant protein and its preparation method and application
  • Acinetobacter baumannii 1a1s_1969 recombinant protein and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Embodiment 1: Cloning of Acinetobacter baumannii A1S_1969 protein

[0058] 1. First, according to the gene sequence of Acinetobacter baumannii 17978 standard strain A1S_1969, its amino acid sequence is shown in SEQ ID NO.3. Bioinformatics software was used for structural analysis, and the signal peptide sequence was as follows: Figure 5 As shown, its spatial structure analysis is as follows Figure 6 shown.

[0059] 2. According to the analysis results, the PCR method is used to amplify the gene fragments of the two fragments of the A1S_1969 protein respectively with the whole genome of Acinetobacter baumannii 17978 as a template (SEQ ID NO.4), and the amplification steps are as follows:

[0060] 1) Design PCR primers as follows, use forward primer P1A1S1969B1 (SEQ ID NO: 9), reverse primer P1A1S1969N2 (SEQ ID NO: 10) to amplify the first fragment, forward primer P2A1S1969B1 (SEQ ID NO: 11), The reverse primer P2A1S1969N2 (SEQ ID NO: 12) amplifies the second fragment...

Embodiment 2

[0103] Example 2: Acinetobacter baumannii-17978 1A1S_1969 protein induced expression, purification and expression form identification in prokaryotic expression system-Escherichia coli

[0104] 1. Induced expression of target protein

[0105] 1) Take 100 μL of the pGEX-6P-2-1A1S_1969 / XL-1blue bacterial solution that was correctly identified by double enzyme digestion and add it to 10 mL of Amp-resistant TB medium, cultivate overnight at 100 rpm at 37°C, take 2 ml of the overnight cultured bacterial solution and add it to 18 mL In the Amp-resistant TB medium (the rest of the bacterial solution is stored in a refrigerator at 4°C for later use), culture at 37°C for 2-3 hours at a rotation speed of 250rpm, and when the secondary activation reaches OD600 of 0.8-1.2, add 4.4 μL of IPTG to make it The final concentration was 200 μM, and then placed on a shaker to induce expression at 30°C for 3 hours, and then induced expression at 16°C overnight.

[0106] 2) Take out the bacterial s...

Embodiment 3

[0112] Embodiment 3: Preparation of 1A1S_1969 protein antigen

[0113] 1. Amplify culture to obtain protein

[0114] Inoculate the pGEX-6P-2-1A1S_1969 / XL-1blue strains stored in the -80°C refrigerator on LB ampicillin-resistant plates, and cultivate overnight at 37°C; pick a single colony and inoculate in 100ml LB ampicillin-resistant medium, 37 Cultivate overnight at 200rpm; add 100ml of activated bacterial liquid to 2L LB medium containing Amp resistance for secondary activation, culture at 37℃ for 3-4h until OD600 is 1.2, add 420ml of IPTG (final concentration is 200uM) After induction in a shaker at 30°C for 3 hours, centrifuge at 6000rpm for 5 minutes to collect the bacteria, add 80ml of PBS to resuspend the bacteria, then ultrasonically lyse the bacteria for 30 minutes, collect the supernatant and 4ml of glutathione-agarose by centrifugation as above Gel 4B binding; a large amount of 1A1S_1969 fusion protein containing GST tag was obtained.

[0115] 2. Use the enzyme d...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to view more

Abstract

The present invention relates to a recombinant protein of 1A1S_1969 and its preparation method and application. The recombinant protein comprises the 46-414th amino acid sequence of A1S_1969. The amino acid sequence of the recombinant protein is shown in SEQ ID NO.5. The recombinant protein has a high expression level, is convenient for separation and purification, is highly efficient and safe, and can be directly used in conjunction with an adjuvant to prepare subunit vaccines against Acinetobacter baumannii infection and related detection kits. It is confirmed by animal experiments that the genetically engineered recombinant monovalent subunit vaccine has a good immune protection effect against Acinetobacter baumannii infection. It lays the foundation for further research on combined vaccines and multi-subunit fusion vaccines, and plays an important role in the development and application of prevention and control vaccines and diagnostic kits.

Description

technical field [0001] The invention belongs to the field of biotechnology, and relates to a protein of Acinetobacter baumannii 1A1S_1969 and a preparation method and application thereof. Background technique [0002] Acinetobacter baumannii (Acinetobacter baumannii) is a non-fermenting Gram-negative bacillus, widely present in water and soil in nature, hospital environment and human skin, respiratory tract, digestive tract and genitourinary tract, and is an opportunistic pathogen. Most of the infected patients are elderly patients, patients with critical illness and weak body resistance, and patients who have used various invasive operations and long-term treatment with broad-spectrum antibiotics. Domestic data show that Acinetobacter baumannii accounts for more than 70% of clinically isolated Acinetobacter. The resistance rate of Acinetobacter baumannii to the third and fourth generation cephalosporins has reached 63.0% to 89.9%. The resistance rate to four aminoglycosid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/22C07K16/12C12N15/31C12N15/70C12N1/21A61K38/16A61P31/04G01N33/569
Inventor 冯强蔡昌芝邹全明曾浩石云敬海明
Owner ARMY MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap